Literature review and expert opinion on the impact of achondroplasia on medical complications and health-related quality of life and expectations for long-term impact of vosoritide: a modified Delphi study.

Author: BaratelaWagner, ButtThomas, Cormier-DaireValérie, FredwallSvein O, IrvingMelita, MillerBradley S, MohnikeKlaus, OzonoKeiichi, RosenfeldRon, SavarirayanRavi, SelicorniAngelo, ThompsonDominic, WhiteKlane K, WrightMichael

Paper Details 
Original Abstract of the Article :
Achondroplasia is associated with disproportionate short stature and significant and potentially severe medical complications. Vosoritide is the first medicine to treat the underlying cause of achondroplasia and data from phase 3 and phase 2 extension studies showed effects on growth and body propor...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195406/

データ提供:米国国立医学図書館(NLM)

Literature Review and Expert Opinion on the Impact of Achondroplasia on Medical Complications and Health-Related Quality of Life and Expectations for Long-Term Impact of Vosoritide: A Modified Delphi Study

The treatment of [achondroplasia] is a complex and challenging area. This study delves into the impact of [achondroplasia] on [medical complications, health-related quality of life (HRQoL), and healthcare resource use] and explores the potential long-term effects of [vosoritide], a novel treatment. It utilizes a [modified Delphi study] to gather expert opinions and synthesize available evidence. This research is a valuable resource for clinicians and patients, offering insights into the long-term implications of achondroplasia and the potential benefits of vosoritide.

Vosoritide for Achondroplasia: Potential Long-Term Impact

The study highlights the significant medical complications and reduced HRQoL associated with achondroplasia. While vosoritide has demonstrated positive effects on growth and body proportions, the study emphasizes the need for further research to assess its long-term impact on these crucial aspects. This research underscores the importance of ongoing research to fully understand the potential benefits and limitations of this promising new treatment.

Improving Outcomes for Patients with Achondroplasia: The Need for Further Research

This study emphasizes the ongoing need for research to address the complex challenges associated with achondroplasia. Understanding the long-term impact of vosoritide on medical complications, HRQoL, and healthcare resource use is crucial for optimizing treatment outcomes and improving the lives of patients with this condition. This research is a vital step towards a brighter future for individuals with achondroplasia.

Dr.Camel's Conclusion

This study is like a desert oasis, offering hope and knowledge to those seeking to understand the complex world of achondroplasia. It reveals the significant challenges associated with this condition but also sheds light on the potential of vosoritide as a treatment option. Further research is key to unlocking the full potential of this promising new therapy and improving the well-being of patients with achondroplasia.

Date :
  1. Date Completed 2022-06-15
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

35698202

DOI: Digital Object Identifier

PMC9195406

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.